Efavirenz-induced neurological symptoms in rare homozygote CYP2B6 *2/*2 (C64T) (vol 18, pg 575, 2007)

被引：0
|
作者：
Usami, O.
Ashino, Y.
Komaki, Y.
机构：
来源：
INTERNATIONAL JOURNAL OF STD & AIDS | 2007年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：726 / 726
页数：1
相关论文
共 50 条
  • [41] Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T allele
    Bordin Andriguetti, Natalia
    Van Schalkwyk, Helena Katherina
    Barratt, Daniel Thomas
    Tucci, Joseph
    Pumuye, Paul
    Somogyi, Andrew Alexander
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (06): : 2521 - 2531
  • [42] High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study
    G Yimer
    W Amogne
    A Habtewold
    E Makonnen
    N Ueda
    A Suda
    A Worku
    W E Haefeli
    J Burhenne
    G Aderaye
    L Lindquist
    E Aklillu
    The Pharmacogenomics Journal, 2012, 12 : 499 - 506
  • [43] Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability
    Artemísia L. Mourão
    Fabiana G. de Abreu
    Marilu Fiegenbaum
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 511 - 515
  • [44] Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children
    Viljoen, M.
    Karlsson, M. O.
    Meyers, T. M.
    Gous, H.
    Dandara, C.
    Rheeders, M.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (04) : 339 - 347
  • [45] CYP2B6 516 G>T polymorphism and side effects of the central nervous system in HIVpositive individuals under Efavirenz treatment: Study of a sample from southern Brazil
    Mueller, Talise E.
    Ellwanger, Joel H.
    Michita, Rafael T.
    Matte, Maria Cristina C.
    Renner, Jane D. P.
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2017, 89 (01): : 497 - 504
  • [46] CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in Botswana
    Vujkovic, Marijana
    Bellamy, Scarlett L.
    Zuppa, Athena F.
    Gastonguay, Marc
    Moorthy, Ganesh S.
    Ratshaa, Bakgaki R.
    Han, Xiaoyan
    Steenhoff, Andrew P.
    Mosepele, Mosepele
    Strom, Brian L.
    Aplenc, Richard
    Bisson, Gregory P.
    Gross, Robert
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 75 (04) : 488 - 491
  • [47] Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability
    Mourao, Artemisia L.
    de Abreu, Fabiana G.
    Fiegenbaum, Marilu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (05) : 511 - 515
  • [48] A natural CYP2B6 TATA box polymorphism (-82T→C) leading to enhanced transcription and relocation of the transcriptional start site
    Zukunft, J
    Lang, T
    Richter, T
    Hirsch-Ernst, KI
    Nussler, AK
    Klein, K
    Schwab, M
    Eichelbaum, M
    Zanger, UM
    MOLECULAR PHARMACOLOGY, 2005, 67 (05) : 1772 - 1782
  • [49] The Relationships of ABCB1 3435C>T and CYP2B6 516G>T With High-Density Lipoprotein Cholesterol in HIV-Infected Patients Receiving Efavirenz
    Mahungu, T. W.
    Nair, D.
    Smith, C. J.
    Egan, D.
    Youle, M.
    Johnson, M. A.
    Khoo, S. H.
    Back, D. J.
    Owen, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (02) : 204 - 211
  • [50] CYP2B6 G516T and ABCB-1 C3435T polymorphisms: implications for efavirenz-associated liver toxicity in HIV/tuberculosis co-infected Thai adults
    Uttayamakul, S.
    Manosuthi, W.
    Likanonsakul, S.
    Shioda, T.
    Khusmith, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 81 - 82
12345